Matches in SemOpenAlex for { <https://semopenalex.org/work/W198828404> ?p ?o ?g. }
- W198828404 endingPage "1416" @default.
- W198828404 startingPage "1411" @default.
- W198828404 abstract "This study sought to evaluate the safety and efficacy of achieving very low calculated low-density lipoprotein (LDL) levels with intensive statin therapy. Intensive statin therapy reduces clinical events occurring after acute coronary syndrome (ACS) and may result in LDL levels markedly lower than guideline levels. Prior epidemiologic and preclinical studies raise concerns about the safety of very low cholesterol levels. The Pravastatin or Atorvastatin Evaluation and Infection Therapy–Thrombolysis In Myocardial Infarction 22 (PROVE IT-TIMI 22) study compared intensive therapy (atorvastatin, 80 mg) and moderate therapy (pravastatin, 40 mg) in patients after ACS. Patients treated with atorvastatin were divided by four-month LDL values into groups: >100, >80 to 100 (reference-range-meeting guidelines), >60 to 80, >40 to 60, and <40 mg/dl. Baseline, clinical, and safety data were compared among groups achieving guideline recommendation levels or lower. Among 1,825 patients with four-month LDL, 91% were at goal (<100 mg/dl). The distribution was >80 to 100 mg/dl (14%), >60 to 80 mg/dl (31%), >40 to 60 mg/dl (34%), and <40 mg/dl (11%). Those with lower LDL levels were more often male, older, and diabetic, and had lower baseline LDL levels. They had prior statin therapy and fewer prior myocardial infarctions (MI). There were no significant differences in safety parameters, including muscle, liver, or retinal abnormalities, intracranial hemorrhage, or death, in the very low LDL groups. The <40 mg/dl and 40 to 60 mg/dl groups had fewer major cardiac events (death, MI, stroke, recurrent ischemia, revascularization). Compared with patients treated with an accepted LDL goal (80 to 100 mg/dl), there was no adverse effect on safety with lower achieved LDL levels, and apparent improved clinical efficacy. These data identify no intrinsic safety concern of achieving low LDL and, therefore, a strategy of intensive treatment need not be altered in patients achieving very low LDL levels." @default.
- W198828404 created "2016-06-24" @default.
- W198828404 creator A5006206326 @default.
- W198828404 creator A5020677154 @default.
- W198828404 creator A5022267024 @default.
- W198828404 creator A5026602252 @default.
- W198828404 creator A5031560506 @default.
- W198828404 creator A5048784526 @default.
- W198828404 creator A5058503662 @default.
- W198828404 date "2005-10-01" @default.
- W198828404 modified "2023-09-27" @default.
- W198828404 title "Can Low-Density Lipoprotein Be Too Low? The Safety and Efficacy of Achieving Very Low Low-Density Lipoprotein With Intensive Statin Therapy" @default.
- W198828404 cites W1994710013 @default.
- W198828404 cites W1995372133 @default.
- W198828404 cites W2018711158 @default.
- W198828404 cites W2019429246 @default.
- W198828404 cites W2027423199 @default.
- W198828404 cites W2057542355 @default.
- W198828404 cites W2058560839 @default.
- W198828404 cites W2058769762 @default.
- W198828404 cites W2059078444 @default.
- W198828404 cites W2089683356 @default.
- W198828404 cites W2090829086 @default.
- W198828404 cites W2102504779 @default.
- W198828404 cites W2110824804 @default.
- W198828404 cites W2124988683 @default.
- W198828404 cites W2135631433 @default.
- W198828404 cites W2137343899 @default.
- W198828404 cites W2139168645 @default.
- W198828404 cites W2159449551 @default.
- W198828404 cites W2160152341 @default.
- W198828404 cites W2163376412 @default.
- W198828404 cites W2165755711 @default.
- W198828404 cites W2321631825 @default.
- W198828404 cites W2608539973 @default.
- W198828404 cites W38523360 @default.
- W198828404 cites W4240735590 @default.
- W198828404 cites W424467158 @default.
- W198828404 doi "https://doi.org/10.1016/j.jacc.2005.04.064" @default.
- W198828404 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16226163" @default.
- W198828404 hasPublicationYear "2005" @default.
- W198828404 type Work @default.
- W198828404 sameAs 198828404 @default.
- W198828404 citedByCount "307" @default.
- W198828404 countsByYear W1988284042012 @default.
- W198828404 countsByYear W1988284042013 @default.
- W198828404 countsByYear W1988284042014 @default.
- W198828404 countsByYear W1988284042015 @default.
- W198828404 countsByYear W1988284042016 @default.
- W198828404 countsByYear W1988284042017 @default.
- W198828404 countsByYear W1988284042018 @default.
- W198828404 countsByYear W1988284042019 @default.
- W198828404 countsByYear W1988284042020 @default.
- W198828404 countsByYear W1988284042021 @default.
- W198828404 countsByYear W1988284042022 @default.
- W198828404 countsByYear W1988284042023 @default.
- W198828404 crossrefType "journal-article" @default.
- W198828404 hasAuthorship W198828404A5006206326 @default.
- W198828404 hasAuthorship W198828404A5020677154 @default.
- W198828404 hasAuthorship W198828404A5022267024 @default.
- W198828404 hasAuthorship W198828404A5026602252 @default.
- W198828404 hasAuthorship W198828404A5031560506 @default.
- W198828404 hasAuthorship W198828404A5048784526 @default.
- W198828404 hasAuthorship W198828404A5058503662 @default.
- W198828404 hasBestOaLocation W1988284041 @default.
- W198828404 hasConcept C126322002 @default.
- W198828404 hasConcept C142724271 @default.
- W198828404 hasConcept C164705383 @default.
- W198828404 hasConcept C2776839432 @default.
- W198828404 hasConcept C2777482532 @default.
- W198828404 hasConcept C2777698277 @default.
- W198828404 hasConcept C2777995511 @default.
- W198828404 hasConcept C2778163477 @default.
- W198828404 hasConcept C2779519902 @default.
- W198828404 hasConcept C2779581417 @default.
- W198828404 hasConcept C2780182762 @default.
- W198828404 hasConcept C500558357 @default.
- W198828404 hasConcept C71924100 @default.
- W198828404 hasConcept C90924648 @default.
- W198828404 hasConceptScore W198828404C126322002 @default.
- W198828404 hasConceptScore W198828404C142724271 @default.
- W198828404 hasConceptScore W198828404C164705383 @default.
- W198828404 hasConceptScore W198828404C2776839432 @default.
- W198828404 hasConceptScore W198828404C2777482532 @default.
- W198828404 hasConceptScore W198828404C2777698277 @default.
- W198828404 hasConceptScore W198828404C2777995511 @default.
- W198828404 hasConceptScore W198828404C2778163477 @default.
- W198828404 hasConceptScore W198828404C2779519902 @default.
- W198828404 hasConceptScore W198828404C2779581417 @default.
- W198828404 hasConceptScore W198828404C2780182762 @default.
- W198828404 hasConceptScore W198828404C500558357 @default.
- W198828404 hasConceptScore W198828404C71924100 @default.
- W198828404 hasConceptScore W198828404C90924648 @default.
- W198828404 hasIssue "8" @default.
- W198828404 hasLocation W1988284041 @default.
- W198828404 hasLocation W1988284042 @default.
- W198828404 hasOpenAccess W198828404 @default.
- W198828404 hasPrimaryLocation W1988284041 @default.